Package 62175-485-37
Brand: verapamil hydrochloride
Generic: verapamil hydrochloridePackage Facts
Identity
Package NDC
62175-485-37
Digits Only
6217548537
Product NDC
62175-485
Description
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62175-485-37)
Marketing
Marketing Status
Brand
verapamil hydrochloride
Generic
verapamil hydrochloride
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c192b40f-4307-483e-bfa7-1619c2f58d7e", "openfda": {"upc": ["0362175486370"], "unii": ["V3888OEY5R"], "rxcui": ["897584", "897590", "897596"], "spl_set_id": ["f3b3580a-4e6b-402f-bf88-f3157d9139b1"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62175-485-37)", "package_ndc": "62175-485-37", "marketing_start_date": "19981125"}], "brand_name": "Verapamil Hydrochloride", "product_id": "62175-485_c192b40f-4307-483e-bfa7-1619c2f58d7e", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "62175-485", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "NDA020943", "marketing_category": "NDA", "marketing_start_date": "19981125", "listing_expiration_date": "20261231"}